CHRS
Coherus Oncology, Inc.
Price Chart
No historical data available
Latest Quote
$1.41
-0.05 (-3.42%)
Current Price
| Previous Close | $1.46 |
| Open | $1.45 |
| Day High | $1.48 |
| Day Low | $1.41 |
| Volume | 605,035 |
Stock Information
| Shares Outstanding | 154.50M |
| Total Debt | $54.18M |
| Cash Equivalents | $105.31M |
| Revenue | $50.94M |
| Net Income | $-161.15M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $217.85M |
| EPS (TTM) | $-1.24 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Coherus Oncology, Inc.
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. It also develops CHS-114, an investigational human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME) patients with head and neck squamous cell carcinoma. It has a collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreements with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc. and Surface and Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. It also has a clinical collaboration agreement with Zumutor Biologics Inc. for the development of LOQTORZI with ZM0008 as a treatment for cancer patients. The company was formerly known as Coherus BioSciences, Inc. and changed its name to Coherus Oncology, Inc. in May 2025. The company was incorporated in 2010 and is based in Redwood City, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on CHRS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $13,814,000 | $8,727,000 | $158,992,000 | $70,083,000 |
| Cost Of Revenue | $13,814,000 | $8,727,000 | $158,992,000 | $70,083,000 |
| Total Revenue | $42,172,000 | $26,389,000 | $257,244,000 | $211,042,000 |
| Operating Revenue | $42,172,000 | $26,389,000 | $257,244,000 | $211,042,000 |
| Expenses | ||||
| Interest Expense | $9,001,000 | $10,734,000 | $40,542,000 | $32,474,000 |
| Total Expenses | $223,306,000 | $226,042,000 | $460,443,000 | $467,922,000 |
| Other Income Expense | $7,011,000 | $-5,007,000 | $5,469,000 | $-2,400,000 |
| Other Non Operating Income Expenses | $7,011,000 | $7,623,000 | $5,469,000 | $3,822,000 |
| Net Non Operating Interest Income Expense | $-9,001,000 | $-10,734,000 | $-40,542,000 | $-32,474,000 |
| Interest Expense Non Operating | $9,001,000 | $10,734,000 | $40,542,000 | $32,474,000 |
| Operating Expense | $209,492,000 | $217,315,000 | $301,451,000 | $397,839,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-183,124,000 | $-215,394,000 | $-237,892,000 | $-291,754,000 |
| Net Interest Income | $-9,001,000 | $-10,734,000 | $-40,542,000 | $-32,474,000 |
| Normalized Income | $-183,124,000 | $-202,764,000 | $-237,892,000 | $-285,532,000 |
| Net Income From Continuing And Discontinued Operation | $168,024,000 | $28,507,000 | $-237,892,000 | $-291,754,000 |
| Total Operating Income As Reported | $-181,134,000 | $-199,653,000 | $-203,199,000 | $-256,880,000 |
| Net Income Common Stockholders | $168,024,000 | $28,507,000 | $-237,892,000 | $-291,754,000 |
| Net Income | $168,024,000 | $28,507,000 | $-237,892,000 | $-291,754,000 |
| Net Income Including Noncontrolling Interests | $168,024,000 | $28,507,000 | $-237,892,000 | $-291,754,000 |
| Net Income Discontinuous Operations | $351,148,000 | $243,901,000 | - | - |
| Net Income Continuous Operations | $-183,124,000 | $-215,394,000 | $-237,892,000 | $-291,754,000 |
| Pretax Income | $-183,124,000 | $-215,394,000 | $-238,272,000 | $-291,754,000 |
| Special Income Charges | $0 | $-12,630,000 | $0 | $-6,222,000 |
| Operating Income | $-181,134,000 | $-199,653,000 | $-203,199,000 | $-256,880,000 |
| Gross Profit | $28,358,000 | $17,662,000 | $98,252,000 | $140,959,000 |
| Average Dilution Earnings | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $1.43 | $0.25 | $-2.53 | $-3.76 |
| Basic EPS | $1.43 | $0.25 | $-2.53 | $-3.76 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-170,199,000 | $-186,754,000 | $-193,939,000 | $-249,359,000 |
| Total Unusual Items | $0 | $-12,630,000 | $0 | $-6,222,000 |
| Total Unusual Items Excluding Goodwill | $0 | $-12,630,000 | $0 | $-6,222,000 |
| Reconciled Depreciation | $3,924,000 | $5,276,000 | $3,791,000 | $3,699,000 |
| EBITDA (Bullshit earnings) | $-170,199,000 | $-199,384,000 | $-193,939,000 | $-255,581,000 |
| EBIT | $-174,123,000 | $-204,660,000 | $-197,730,000 | $-259,280,000 |
| Diluted Average Shares | $117,143,457 | $114,830,462 | $94,162,637 | $77,630,020 |
| Basic Average Shares | $117,143,457 | $114,553,537 | $94,162,637 | $77,630,020 |
| Diluted NI Availto Com Stockholders | $168,024,000 | $28,507,000 | $-237,892,000 | $-291,754,000 |
| Tax Provision | $0 | $0 | $-380,000 | $0 |
| Research And Development | $108,888,000 | $91,833,000 | $109,436,000 | $199,358,000 |
| Selling General And Administration | $100,604,000 | $125,482,000 | $192,015,000 | $198,481,000 |
| Gain On Sale Of Business | - | $176,589,000 | $0 | $0 |
| Other Special Charges | - | $12,630,000 | - | $6,222,000 |
Fetched: 2026-08-28
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $14,775,000 | $-185,636,000 | $-265,098,000 | $-143,349,000 |
| Total Assets | $258,343,000 | $448,533,000 | $629,604,000 | $480,847,000 |
| Total Non Current Assets | $51,637,000 | $106,950,000 | $153,973,000 | $99,613,000 |
| Other Non Current Assets | $4,053,000 | $50,728,000 | $77,181,000 | $84,928,000 |
| Goodwill And Other Intangible Assets | $46,239,000 | $53,646,000 | $71,673,000 | $5,931,000 |
| Other Intangible Assets | $46,239,000 | $53,646,000 | $70,730,000 | $4,988,000 |
| Current Assets | $206,706,000 | $341,583,000 | $475,631,000 | $381,234,000 |
| Other Current Assets | $6,233,000 | $10,222,000 | $11,099,000 | $22,918,000 |
| Assets Held For Sale Current | $0 | $72,180,000 | - | - |
| Prepaid Assets | $6,758,000 | $6,653,000 | $23,657,000 | $17,880,000 |
| Inventory | $3,172,000 | $4,207,000 | $62,605,000 | $38,791,000 |
| Receivables | $18,418,000 | $122,334,000 | $260,522,000 | $109,964,000 |
| Other Receivables | $603,000 | $11,010,000 | - | - |
| Accounts Receivable | $17,815,000 | $111,324,000 | $260,522,000 | $109,964,000 |
| Cash Cash Equivalents And Short Term Investments | $172,125,000 | $125,987,000 | $117,748,000 | $191,681,000 |
| Cash And Cash Equivalents | $88,879,000 | $125,987,000 | $102,891,000 | $63,547,000 |
| Debt | ||||
| Total Debt | $40,336,000 | $269,904,000 | $480,842,000 | $480,422,000 |
| Long Term Debt And Capital Lease Obligation | $38,508,000 | $268,213,000 | $478,697,000 | $476,104,000 |
| Long Term Debt | $37,051,000 | $264,927,000 | $473,369,000 | $471,058,000 |
| Current Debt And Capital Lease Obligation | $1,828,000 | $1,691,000 | $2,145,000 | $4,318,000 |
| Net Debt | - | $138,940,000 | $370,478,000 | $407,511,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $197,329,000 | $580,523,000 | $823,029,000 | $618,265,000 |
| Total Non Current Liabilities Net Minority Interest | $55,453,000 | $297,542,000 | $491,258,000 | $479,571,000 |
| Other Non Current Liabilities | $15,843,000 | $28,227,000 | $11,459,000 | $3,467,000 |
| Non Current Deferred Liabilities | $1,102,000 | $1,102,000 | $1,102,000 | $0 |
| Non Current Deferred Taxes Liabilities | $1,102,000 | $1,102,000 | $1,102,000 | $0 |
| Current Liabilities | $141,876,000 | $282,981,000 | $331,771,000 | $138,694,000 |
| Other Current Liabilities | $1,490,000 | $13,620,000 | - | - |
| Payables And Accrued Expenses | $123,979,000 | $249,326,000 | $308,105,000 | $111,766,000 |
| Payables | $9,915,000 | $28,456,000 | $35,219,000 | $11,526,000 |
| Accounts Payable | $9,915,000 | $28,456,000 | $35,219,000 | $11,526,000 |
| Equity | ||||
| Common Stock Equity | $61,014,000 | $-131,990,000 | $-193,425,000 | $-137,418,000 |
| Total Equity Gross Minority Interest | $61,014,000 | $-131,990,000 | $-193,425,000 | $-137,418,000 |
| Stockholders Equity | $61,014,000 | $-131,990,000 | $-193,425,000 | $-137,418,000 |
| Gains Losses Not Affecting Retained Earnings | $-195,000 | $-275,000 | $-248,000 | $-249,000 |
| Other Equity Adjustments | $-195,000 | $-275,000 | $-248,000 | $-249,000 |
| Retained Earnings | $-1,382,969,000 | $-1,550,993,000 | $-1,579,500,000 | $-1,341,608,000 |
| Other | ||||
| Ordinary Shares Number | $121,154,925 | $115,614,548 | $112,215,260 | $78,851,516 |
| Share Issued | $121,154,925 | $115,614,548 | $112,215,260 | $78,851,516 |
| Tangible Book Value | $14,775,000 | $-185,636,000 | $-265,098,000 | $-143,349,000 |
| Invested Capital | $98,065,000 | $132,937,000 | $279,944,000 | $333,640,000 |
| Working Capital | $64,830,000 | $58,602,000 | $143,860,000 | $242,540,000 |
| Capital Lease Obligations | $3,285,000 | $4,977,000 | $7,473,000 | $9,364,000 |
| Total Capitalization | $98,065,000 | $132,937,000 | $279,944,000 | $333,640,000 |
| Additional Paid In Capital | $1,444,166,000 | $1,419,266,000 | $1,386,312,000 | $1,204,431,000 |
| Capital Stock | $12,000 | $12,000 | $11,000 | $8,000 |
| Common Stock | $12,000 | $12,000 | $11,000 | $8,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,457,000 | $3,286,000 | $5,328,000 | $5,046,000 |
| Current Capital Lease Obligation | $1,828,000 | $1,691,000 | $2,145,000 | $4,318,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $14,579,000 | $18,344,000 | $21,521,000 | $22,610,000 |
| Current Accrued Expenses | $114,064,000 | $220,870,000 | $272,886,000 | $100,240,000 |
| Net PPE | $1,345,000 | $2,576,000 | $5,119,000 | $8,754,000 |
| Accumulated Depreciation | $-15,233,000 | $-20,988,000 | $-20,651,000 | $-20,157,000 |
| Gross PPE | $16,578,000 | $23,564,000 | $25,770,000 | $28,911,000 |
| Leases | $5,763,000 | $5,751,000 | $5,751,000 | $6,198,000 |
| Machinery Furniture Equipment | $10,815,000 | $18,074,000 | $17,725,000 | $17,385,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $83,246,000 | $0 | $14,857,000 | $128,134,000 |
| Goodwill | - | $0 | $943,000 | $943,000 |
| Other Properties | - | $-261,000 | $2,294,000 | $4,632,000 |
| Construction In Progress | - | - | $0 | $696,000 |
Fetched: 2026-08-28
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-138,513,000 | $-20,440,000 | $-174,884,000 | $-241,124,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-138,513,000 | $-20,440,000 | $-174,884,000 | $-241,124,000 |
| Cash Flow From Continuing Operating Activities | $-138,513,000 | $-20,440,000 | $-174,884,000 | $-241,124,000 |
| Operating Gains Losses | $-315,421,000 | $-158,916,000 | $375,000 | $41,222,000 |
| Investing Activities | ||||
| Investing Cash Flow | $375,087,000 | $230,321,000 | $144,640,000 | $-166,850,000 |
| Cash Flow From Continuing Investing Activities | $375,087,000 | $230,321,000 | $144,640,000 | $-166,850,000 |
| Net Other Investing Changes | $-342,000 | $110,000 | $-492,000 | $-4,468,000 |
| Capital Expenditure | - | - | $-286,000 | $-2,039,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,894,000 | $1,455,000 | $71,718,000 | $6,358,000 |
| Financing Cash Flow | $-273,705,000 | $-186,974,000 | $69,600,000 | $54,326,000 |
| Cash Flow From Continuing Financing Activities | $-273,705,000 | $-186,974,000 | $69,600,000 | $54,326,000 |
| Net Other Financing Charges | $-1,115,000 | $34,053,000 | $-4,621,000 | $-4,972,000 |
| Net Common Stock Issuance | $7,894,000 | $1,455,000 | $71,718,000 | $6,358,000 |
| Common Stock Issuance | $7,894,000 | $1,455,000 | $71,718,000 | $6,358,000 |
| Other | ||||
| Repayment Of Debt | $-280,837,000 | $-260,387,000 | $0 | $-190,750,000 |
| Interest Paid Supplemental Data | $9,916,000 | $25,376,000 | $37,857,000 | $34,878,000 |
| Income Tax Paid Supplemental Data | $36,000 | - | - | $40,000 |
| End Cash Position | $89,119,000 | $126,250,000 | $103,343,000 | $63,987,000 |
| Beginning Cash Position | $126,250,000 | $103,343,000 | $63,987,000 | $417,635,000 |
| Changes In Cash | $-37,131,000 | $22,907,000 | $39,356,000 | $-353,648,000 |
| Proceeds From Stock Option Exercised | $353,000 | $926,000 | $2,503,000 | $3,011,000 |
| Net Issuance Payments Of Debt | $-280,837,000 | $-223,408,000 | $0 | $49,929,000 |
| Net Long Term Debt Issuance | $-280,837,000 | $-223,408,000 | $0 | $49,929,000 |
| Long Term Debt Payments | $-280,837,000 | $-260,387,000 | $0 | $-190,750,000 |
| Net Investment Purchase And Sale | $-82,376,000 | $14,888,000 | $138,135,000 | $-127,382,000 |
| Sale Of Investment | $21,462,000 | $14,888,000 | $157,642,000 | $0 |
| Purchase Of Investment | $-103,838,000 | $0 | $-19,507,000 | $-127,382,000 |
| Net Business Purchase And Sale | $457,805,000 | $215,323,000 | $6,997,000 | $-35,000,000 |
| Sale Of Business | $470,305,000 | $227,823,000 | $6,997,000 | $0 |
| Purchase Of Business | $-12,500,000 | $-12,500,000 | $0 | $-35,000,000 |
| Change In Working Capital | $-5,842,000 | $55,894,000 | $-36,826,000 | $-79,257,000 |
| Change In Other Working Capital | $64,446,000 | - | - | $596,000 |
| Change In Payables And Accrued Expense | $-151,847,000 | $-65,330,000 | $142,409,000 | $-27,323,000 |
| Change In Accrued Expense | $-132,291,000 | $-61,392,000 | $118,649,000 | $-22,775,000 |
| Change In Payable | $-19,556,000 | $-3,938,000 | $23,760,000 | $-4,548,000 |
| Change In Account Payable | $-19,556,000 | $-3,938,000 | $23,760,000 | $-4,548,000 |
| Change In Prepaid Assets | $5,110,000 | $3,826,000 | $18,182,000 | $-17,638,000 |
| Change In Inventory | $-17,108,000 | $-31,952,000 | $-46,734,000 | $-47,348,000 |
| Change In Receivables | $93,557,000 | $149,350,000 | $-150,683,000 | $13,052,000 |
| Changes In Account Receivables | $93,557,000 | $149,350,000 | $-150,683,000 | $13,052,000 |
| Other Non Cash Items | $-10,328,000 | $82,000 | $-37,000 | $8,229,000 |
| Stock Based Compensation | $16,966,000 | $27,802,000 | $43,110,000 | $50,737,000 |
| Asset Impairment Charge | $4,164,000 | $20,915,000 | $52,595,000 | $26,000,000 |
| Depreciation Amortization Depletion | $3,924,000 | $5,276,000 | $3,791,000 | $3,699,000 |
| Depreciation And Amortization | $3,924,000 | $5,276,000 | $3,791,000 | $3,699,000 |
| Gain Loss On Investment Securities | $12,608,000 | $5,043,000 | $375,000 | $35,000,000 |
| Gain Loss On Sale Of Business | $-338,315,000 | $-176,589,000 | $0 | $0 |
| Net Income From Continuing Operations | $168,024,000 | $28,507,000 | $-237,892,000 | $-291,754,000 |
| Issuance Of Debt | - | $36,979,000 | $0 | $240,679,000 |
| Long Term Debt Issuance | - | $36,979,000 | $0 | $240,679,000 |
| Net PPE Purchase And Sale | - | - | $559,000 | $-2,039,000 |
| Sale Of PPE | - | - | $845,000 | $0 |
| Purchase Of PPE | - | - | $-286,000 | $-2,039,000 |
| Amortization Of Securities | - | - | $-3,052,000 | $-730,000 |
| Effect Of Exchange Rate Changes | - | - | - | - |
Fetched: 2026-08-28